Isothermal Titration Calorimetry (ITC) directly measures the thermodynamics of molecular interactions by monitoring heat released or absorbed during binding. The technique provides a comprehensive interaction profile, including binding affinity (Kd), stoichiometry (n), enthalpy (ΔH), and entropy (ΔS).
As a label-free, solution-based method, ITC is suitable for protein–ligand, protein–protein, and nucleic-acid interactions. It supports detailed characterization of binding mechanisms in drug discovery, lead optimization, and biomolecular research.
In an ITC assay, a solution containing the ligand is gradually titrated into a solution containing the target molecule under isothermal conditions. The heat released or absorbed during each binding event is measured with high sensitivity, enabling calculation of binding affinity (Kd), stoichiometry (n), enthalpy (ΔH), and entropy (ΔS).

Highly active, in-house produced proteins support a broad range of biophysical assays with high precision, reliability, and reproducibility.
ITC operates under label-free, native conditions and can provide Kd, ΔH, ΔS, ΔG, and binding stoichiometry in a single experiment.
The solution-based format is robust with turbid or colored samples and does not require optical clarity for measurement.
Suitable for protein–protein, protein–small-molecule, and enzyme–ligand interaction studies.
AK-1690, a STAT6 SH2-domain-targeted PROTAC reported by Wang et al. (2024), was titrated into the non-phosphorylated STAT6 core domain using PEAQ-ITC™. The ITC data were analyzed with the “One Set of Sites” model.
The binding affinity measured by ITC was comparable to the value obtained by SPR (KD = 33.7 nM). The interaction was driven by both enthalpy (ΔH) and entropy (TΔS) changes. The ITC n value of 1.18 confirmed an approximately 1:1 molar ratio of STAT6 to AK-1690 binding.

ITC binding isotherm of AK-1690 to STAT6.

Binding energetics of AK-1690 and STAT6.
ITC-derived binding parameters for the AK-1690–STAT6 interaction are summarized below.

We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Get a quote
Go top